Day 2 :
Keynote Forum
Helieh S. Oz
UK Medical Center
Keynote: Colorectal neoplasia predispositions, basic, translational to bedside approaches
Biography:
Helieh S. Oz has a DVM, MS (U IL); Ph.D. (U MN) and clinical translational research certificate (UKY). SHE is an active member of the American Association of Gastroenterology (AGA) and AGA Fellow (AGAF) and associate in Rome Foundation (Functional Gastrointestinal Diseases). She is an Immuno-Microbiologist with expertise in inflammatory/infectious diseases, drugs discovery, pathogenesis, innate/mucosal Immunity, molecular biology, reactive oxygen radicals, antioxidants, polyphenols and micronutrient, animal models and pain-related behavioral modifications. She has over 90 publications and served as Lead Editor for special issues including gut inflammatory, infectious diseases and nutrition 2017 (Mediators of Inflammation); gastrointestinal inflammation, repair: the role of microbiome, infection, nutrition (Gastroenterology Research Practice), Journal of Nutrient and guest Editor for Journal of Pediatric Infectious Disease. She serves on different Editorial Advisory Board Committees including Center of Excellence for Medical Research and Innovative Products, Walailak University Thailand and is an avid reviewer for several peer-reviewed journals.
Abstract:
Colorectal malignancy, the 3rd most important malignant complications with a high tendency for metastasis, is caused by risk factors such as lifestyle, dietary, race, and aging or due to the underlying genetic predispositions (e.g. familial adenomatous polyposis). It is mainly common in patients with chronic idiopathic inflammatory bowel disease (IBD), as there is no cure for IBD. IBD patients are predestined to have a colostomy or to develop colorectal malignancy; suggesting a profound relationship between the chronic inflammation and susceptibility to acquiring colorectal neoplasia. Dysplasia is mainly originated from intestinal epithelial cells lining (IEC-cells) in the colon or rectum with altered apoptosis as a result of a mutation in the Wnt signaling pathway with increase signaling and activity in the intestinal crypt stem cell. Further, local microbial dysbiosis is predicted to contribute to functional changes at the cancerous sites. Various animals serve as models for dysplasia and carcinoma including chemical exposure or genetically altered animals. IL-10-deficient mice when exposed to normal gut flora develop severe enterocolitis followed by the rectal prolapse. Yet, when these animals are kept in our germfree environment eventually develop dysplasia and colorectal neoplasia. Surgery is the elective approach for colorectal malignancy, yet the morbidity rate following colorectal resection remains as high as 24%-43%. The postsurgical complications include tissue adhesions at the site of surgery, infection, anastomotic leakage, impaired bowel movement and malfunction as a transient or prolonged impediment which delay recovery and increase the length of hospitalization followed by acquired infections, sepsis, and possible death. Postoperative infections seriously affect the prognosis of cancer patients, while probiotics have been increasingly used to prevent postoperative infection in clinical practice. This presentation will review colorectal malignancies and explore the mechanism of actions for ongoing and prospective protective effects of interventions and possible adverse effects and safety issues.
Keynote Forum
Pandurangan Ramaraj
A.T.Still University of Health Sciences
Keynote: Biochemical Basis of Steroid Hormones Protective Function In Melanoma Based On Human Melanoma Cell Models & The Impact on Clinical Treatment of Melanoma
Keynote Forum
Yoshiaki Omura
New York Medical College
Keynote: Very Significant Beneficial Effects of Combined Optimal Doses of Vitamin D3 with 10 Unique Beneficial Effects & Dragon Fruit Containing DHEA, Zinc, Magnesium, Lithium, etc. & Additional Selective Drug Uptake Enhancement Method and Manual Stimulation of Newly Discovered Thymus Gland Representation Area on the Back of Each Hand for Treatment of Hopelessly Advanced Cancer with Multiple Metastases.
Keynote Forum
Vikas Leelavati Balasaheb Jadhav
Dr.D.Y.Patil University
Keynote: Sonography of the Gastro-Intestinal Tract for Neoplastic Disease & Non-Neoplastic Disease
Keynote Forum
David A. Boothman
Indiana University